

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | viral transcription (GO:0019083) | 6.81503620 |
| 2 | translational termination (GO:0006415) | 6.54731108 |
| 3 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 6.35363329 |
| 4 | cotranslational protein targeting to membrane (GO:0006613) | 6.26042567 |
| 5 | protein targeting to ER (GO:0045047) | 6.23875383 |
| 6 | ribosomal small subunit assembly (GO:0000028) | 6.13199368 |
| 7 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 5.93730559 |
| 8 | protein localization to endoplasmic reticulum (GO:0070972) | 5.86116613 |
| 9 | translational elongation (GO:0006414) | 5.62446730 |
| 10 | ribosomal small subunit biogenesis (GO:0042274) | 5.62123371 |
| 11 | DNA deamination (GO:0045006) | 5.42444859 |
| 12 | viral life cycle (GO:0019058) | 5.14509622 |
| 13 | cellular protein complex disassembly (GO:0043624) | 5.01438058 |
| 14 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 4.85998678 |
| 15 | translational initiation (GO:0006413) | 4.85230296 |
| 16 | maturation of SSU-rRNA (GO:0030490) | 4.37074811 |
| 17 | ribosomal large subunit biogenesis (GO:0042273) | 4.32628956 |
| 18 | protein complex disassembly (GO:0043241) | 4.31493536 |
| 19 | telomere maintenance via semi-conservative replication (GO:0032201) | 4.24228240 |
| 20 | protein targeting to membrane (GO:0006612) | 4.18853104 |
| 21 | DNA strand elongation involved in DNA replication (GO:0006271) | 4.10115913 |
| 22 | translation (GO:0006412) | 4.08429118 |
| 23 | macromolecular complex disassembly (GO:0032984) | 4.08280635 |
| 24 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.03606441 |
| 25 | DNA strand elongation (GO:0022616) | 3.85431101 |
| 26 | oligosaccharide catabolic process (GO:0009313) | 3.82581233 |
| 27 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.82549920 |
| 28 | neutrophil activation involved in immune response (GO:0002283) | 3.76525278 |
| 29 | telomere maintenance via recombination (GO:0000722) | 3.67942083 |
| 30 | Golgi transport vesicle coating (GO:0048200) | 3.57371617 |
| 31 | COPI coating of Golgi vesicle (GO:0048205) | 3.57371617 |
| 32 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.56639649 |
| 33 | respiratory burst (GO:0045730) | 3.55941611 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.52578276 |
| 35 | regulation of superoxide anion generation (GO:0032928) | 3.49705470 |
| 36 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.46463188 |
| 37 | GDP-mannose metabolic process (GO:0019673) | 3.42176213 |
| 38 | formation of translation preinitiation complex (GO:0001731) | 3.41166804 |
| 39 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 3.40461658 |
| 40 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.39027572 |
| 41 | glycosphingolipid catabolic process (GO:0046479) | 3.36126009 |
| 42 | neutrophil mediated immunity (GO:0002446) | 3.32688437 |
| 43 | amino sugar catabolic process (GO:0046348) | 3.32486741 |
| 44 | DNA replication checkpoint (GO:0000076) | 3.29316232 |
| 45 | mRNA catabolic process (GO:0006402) | 3.28668480 |
| 46 | mitotic recombination (GO:0006312) | 3.25011584 |
| 47 | ribonucleoprotein complex biogenesis (GO:0022613) | 3.23875399 |
| 48 | regulation of protein heterodimerization activity (GO:0043497) | 3.23669080 |
| 49 | DNA replication initiation (GO:0006270) | 3.22912544 |
| 50 | signal peptide processing (GO:0006465) | 3.22717889 |
| 51 | L-alpha-amino acid transmembrane transport (GO:1902475) | 3.18006959 |
| 52 | DNA unwinding involved in DNA replication (GO:0006268) | 3.16986692 |
| 53 | RNA catabolic process (GO:0006401) | 3.10118075 |
| 54 | negative regulation of phagocytosis (GO:0050765) | 3.08788726 |
| 55 | mannose metabolic process (GO:0006013) | 3.07049926 |
| 56 | immunoglobulin mediated immune response (GO:0016064) | 3.03972073 |
| 57 | glycolipid catabolic process (GO:0019377) | 3.02571289 |
| 58 | lipopolysaccharide metabolic process (GO:0008653) | 3.00031368 |
| 59 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.99419697 |
| 60 | response to thyroid hormone (GO:0097066) | 2.98718953 |
| 61 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.97357717 |
| 62 | NADPH regeneration (GO:0006740) | 2.97069820 |
| 63 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.94782469 |
| 64 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.94767987 |
| 65 | telomere maintenance via telomere lengthening (GO:0010833) | 2.93809463 |
| 66 | cellular response to interferon-beta (GO:0035458) | 2.90025179 |
| 67 | establishment of protein localization to membrane (GO:0090150) | 2.89474543 |
| 68 | ncRNA 3-end processing (GO:0043628) | 2.87467217 |
| 69 | pentose metabolic process (GO:0019321) | 2.87378376 |
| 70 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO | 2.87129194 |
| 71 | mitotic nuclear envelope reassembly (GO:0007084) | 2.85794877 |
| 72 | nuclear envelope reassembly (GO:0031468) | 2.85794877 |
| 73 | glucose catabolic process (GO:0006007) | 2.84687172 |
| 74 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.84009123 |
| 75 | protein maturation by protein folding (GO:0022417) | 2.83161409 |
| 76 | rRNA processing (GO:0006364) | 2.81050202 |
| 77 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.79339690 |
| 78 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.79037750 |
| 79 | protein retention in ER lumen (GO:0006621) | 2.78437603 |
| 80 | pseudouridine synthesis (GO:0001522) | 2.78138198 |
| 81 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.77946526 |
| 82 | protein targeting (GO:0006605) | 2.76190058 |
| 83 | pinocytosis (GO:0006907) | 2.76046594 |
| 84 | amyloid precursor protein catabolic process (GO:0042987) | 2.73198910 |
| 85 | proline biosynthetic process (GO:0006561) | 2.72662578 |
| 86 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.72469719 |
| 87 | actin nucleation (GO:0045010) | 2.72036021 |
| 88 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 2.71759562 |
| 89 | response to peptidoglycan (GO:0032494) | 2.71031792 |
| 90 | GTP biosynthetic process (GO:0006183) | 2.67955023 |
| 91 | rRNA metabolic process (GO:0016072) | 2.67073698 |
| 92 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.66587606 |
| 93 | glucose 6-phosphate metabolic process (GO:0051156) | 2.66361646 |
| 94 | response to interferon-beta (GO:0035456) | 2.65539300 |
| 95 | pentose-phosphate shunt (GO:0006098) | 2.65072995 |
| 96 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.64999543 |
| 97 | leukocyte mediated cytotoxicity (GO:0001909) | 2.61860627 |
| 98 | purine ribonucleotide transport (GO:0015868) | 2.61773751 |
| 99 | positive regulation of B cell differentiation (GO:0045579) | 2.61404270 |
| 100 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.61102622 |
| 101 | ATP synthesis coupled proton transport (GO:0015986) | 2.61102622 |
| 102 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.60616502 |
| 103 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.60616502 |
| 104 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.59614778 |
| 105 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.57490056 |
| 106 | establishment of protein localization to organelle (GO:0072594) | 2.57072191 |
| 107 | N-acetylneuraminate metabolic process (GO:0006054) | 2.56918705 |
| 108 | cellular component biogenesis (GO:0044085) | 2.55814426 |
| 109 | sphingolipid catabolic process (GO:0030149) | 2.54860563 |
| 110 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.54714696 |
| 111 | negative regulation of ligase activity (GO:0051352) | 2.54714696 |
| 112 | UTP biosynthetic process (GO:0006228) | 2.54285311 |
| 113 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.54082215 |
| 114 | myeloid leukocyte mediated immunity (GO:0002444) | 2.53972689 |
| 115 | B cell mediated immunity (GO:0019724) | 2.53575529 |
| 116 | establishment of viral latency (GO:0019043) | 2.52343499 |
| 117 | response to fungus (GO:0009620) | 2.52197245 |
| 118 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.52097392 |
| 119 | ceramide catabolic process (GO:0046514) | 2.51644459 |
| 120 | cellular response to thyroid hormone stimulus (GO:0097067) | 2.51064324 |
| 121 | pyrimidine nucleoside triphosphate metabolic process (GO:0009147) | 2.50588273 |
| 122 | cellular response to zinc ion (GO:0071294) | 2.48929381 |
| 123 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.47686445 |
| 124 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.47686445 |
| 125 | positive regulation of antigen processing and presentation (GO:0002579) | 2.46251608 |
| 126 | regulation of translational fidelity (GO:0006450) | 2.44943881 |
| 127 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.43492820 |
| 128 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.43472646 |
| 129 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.43472646 |
| 130 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.43472646 |
| 131 | membrane lipid catabolic process (GO:0046466) | 2.43267056 |
| 132 | establishment of integrated proviral latency (GO:0075713) | 2.42997549 |
| 133 | CTP biosynthetic process (GO:0006241) | 2.40436137 |
| 134 | CTP metabolic process (GO:0046036) | 2.40436137 |
| 135 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.35959619 |
| 136 | L-phenylalanine metabolic process (GO:0006558) | 2.35959619 |
| 137 | viral protein processing (GO:0019082) | 2.34315740 |
| 138 | regulation of autophagic vacuole assembly (GO:2000785) | 2.33754616 |
| 139 | regulation of extracellular matrix disassembly (GO:0010715) | 2.32610293 |
| 140 | myeloid cell homeostasis (GO:0002262) | 2.32111032 |
| 141 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.30688764 |
| 142 | regulation of mitochondrial translation (GO:0070129) | 2.28362063 |
| 143 | regulation of lipoprotein particle clearance (GO:0010984) | 2.21899715 |
| 144 | respiratory electron transport chain (GO:0022904) | 2.21432976 |
| 145 | adenine nucleotide transport (GO:0051503) | 2.20320965 |
| 146 | modulation by symbiont of host immune response (GO:0052553) | 2.18616284 |
| 147 | positive regulation by symbiont of host defense response (GO:0052509) | 2.18616284 |
| 148 | modulation by symbiont of host defense response (GO:0052031) | 2.18616284 |
| 149 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.18616284 |
| 150 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.18616284 |
| 151 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.18616284 |
| 152 | modulation by virus of host process (GO:0019054) | 2.16192076 |
| 153 | electron transport chain (GO:0022900) | 2.15686470 |
| 154 | regulation of B cell apoptotic process (GO:0002902) | 2.15539461 |
| 155 | oxidative phosphorylation (GO:0006119) | 2.15066394 |
| 156 | detection of bacterium (GO:0016045) | 2.14773775 |
| 157 | modulation by symbiont of host cellular process (GO:0044068) | 2.11515525 |
| 158 | regulation of cholesterol esterification (GO:0010872) | 2.11017546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 5.52781399 |
| 2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 4.05700171 |
| 3 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 4.01331846 |
| 4 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.62081758 |
| 5 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.06124037 |
| 6 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.02317269 |
| 7 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.90280248 |
| 8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.87019136 |
| 9 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.83965395 |
| 10 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.78155820 |
| 11 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.76291048 |
| 12 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.66664107 |
| 13 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.64472567 |
| 14 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.54916266 |
| 15 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.49854118 |
| 16 | * IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.46970058 |
| 17 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.43310272 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.43008352 |
| 19 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.37369698 |
| 20 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.26923157 |
| 21 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.26415779 |
| 22 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.22880455 |
| 23 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.22127967 |
| 24 | XRN2_22483619_ChIP-Seq_HELA_Human | 2.20695293 |
| 25 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.15083477 |
| 26 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.13910781 |
| 27 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.12164383 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.08399338 |
| 29 | * DCP1A_22483619_ChIP-Seq_HELA_Human | 2.05255554 |
| 30 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.02957761 |
| 31 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.92230342 |
| 32 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.91133065 |
| 33 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.87141873 |
| 34 | * PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.86868454 |
| 35 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.86794397 |
| 36 | * ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.86754869 |
| 37 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.86615604 |
| 38 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.85898866 |
| 39 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.82646565 |
| 40 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.81656029 |
| 41 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.81482015 |
| 42 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.80592850 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.79020930 |
| 44 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.77849417 |
| 45 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.75494948 |
| 46 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.74598997 |
| 47 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.72892791 |
| 48 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.69197637 |
| 49 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.68605446 |
| 50 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.65637627 |
| 51 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.65384121 |
| 52 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.63748487 |
| 53 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.63735966 |
| 54 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.62914655 |
| 55 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.58679327 |
| 56 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.55390515 |
| 57 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.55389592 |
| 58 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.55282263 |
| 59 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.54890390 |
| 60 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.52680389 |
| 61 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.52028754 |
| 62 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.50508211 |
| 63 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.50362729 |
| 64 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.49289265 |
| 65 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.45112810 |
| 66 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.42476178 |
| 67 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.38951992 |
| 68 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.38207775 |
| 69 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.36828230 |
| 70 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.36530216 |
| 71 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.35296650 |
| 72 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.34211273 |
| 73 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.33554256 |
| 74 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.32922414 |
| 75 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.31423959 |
| 76 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.31072379 |
| 77 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.30531043 |
| 78 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.29832097 |
| 79 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.28662957 |
| 80 | * RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.26262797 |
| 81 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.26102111 |
| 82 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.25996685 |
| 83 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.25858833 |
| 84 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.24629969 |
| 85 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21746693 |
| 86 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.21276869 |
| 87 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.20860797 |
| 88 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.20533916 |
| 89 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.19785660 |
| 90 | * BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.18296623 |
| 91 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.17817994 |
| 92 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.17429613 |
| 93 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.17154541 |
| 94 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.17081198 |
| 95 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.15812517 |
| 96 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.15551495 |
| 97 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.14861948 |
| 98 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.14509265 |
| 99 | P68_20966046_ChIP-Seq_HELA_Human | 1.12020795 |
| 100 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.11943159 |
| 101 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11637679 |
| 102 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.10909888 |
| 103 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.10417552 |
| 104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09272122 |
| 105 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09209094 |
| 106 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.08918441 |
| 107 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.08769272 |
| 108 | MAF_26560356_Chip-Seq_TH1_Human | 1.08402341 |
| 109 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.07386016 |
| 110 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05762329 |
| 111 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.05179234 |
| 112 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.03837880 |
| 113 | UTX_26944678_Chip-Seq_JUKART_Human | 1.01804718 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01659484 |
| 115 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.01104870 |
| 116 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.00049492 |
| 117 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.99396785 |
| 118 | MYB_26560356_Chip-Seq_TH2_Human | 0.98318951 |
| 119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.97718847 |
| 120 | * DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.97587859 |
| 121 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.97312290 |
| 122 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97100196 |
| 123 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.95693920 |
| 124 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 0.95194977 |
| 125 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.94289699 |
| 126 | MAF_26560356_Chip-Seq_TH2_Human | 0.94032286 |
| 127 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.93259211 |
| 128 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 0.92997973 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0001835_abnormal_antigen_presentation | 3.93288391 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 3.47524491 |
| 3 | MP0003693_abnormal_embryo_hatching | 3.32220212 |
| 4 | MP0005058_abnormal_lysosome_morphology | 3.16996325 |
| 5 | MP0003303_peritoneal_inflammation | 3.02659745 |
| 6 | MP0003436_decreased_susceptibility_to | 2.97104113 |
| 7 | MP0009840_abnormal_foam_cell | 2.96367466 |
| 8 | MP0009379_abnormal_foot_pigmentation | 2.77739647 |
| 9 | MP0002148_abnormal_hypersensitivity_rea | 2.64421688 |
| 10 | MP0005174_abnormal_tail_pigmentation | 2.59359179 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.56058657 |
| 12 | MP0002396_abnormal_hematopoietic_system | 2.53258797 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.48404240 |
| 14 | MP0002419_abnormal_innate_immunity | 2.44438737 |
| 15 | MP0003172_abnormal_lysosome_physiology | 2.38921992 |
| 16 | MP0005025_abnormal_response_to | 2.38534602 |
| 17 | MP0004957_abnormal_blastocyst_morpholog | 2.36160464 |
| 18 | MP0009333_abnormal_splenocyte_physiolog | 2.31118440 |
| 19 | MP0002452_abnormal_antigen_presenting | 2.29034417 |
| 20 | MP0001800_abnormal_humoral_immune | 2.18419511 |
| 21 | MP0009785_altered_susceptibility_to | 2.16451955 |
| 22 | MP0000490_abnormal_crypts_of | 2.14592079 |
| 23 | MP0002420_abnormal_adaptive_immunity | 2.12078461 |
| 24 | MP0001819_abnormal_immune_cell | 2.10014774 |
| 25 | MP0000685_abnormal_immune_system | 2.07907737 |
| 26 | MP0005365_abnormal_bile_salt | 2.07468469 |
| 27 | MP0002723_abnormal_immune_serum | 2.04480579 |
| 28 | MP0005451_abnormal_body_composition | 2.03557238 |
| 29 | MP0003183_abnormal_peptide_metabolism | 1.94510341 |
| 30 | MP0006054_spinal_hemorrhage | 1.93707988 |
| 31 | MP0005387_immune_system_phenotype | 1.91314380 |
| 32 | MP0001790_abnormal_immune_system | 1.91314380 |
| 33 | MP0002398_abnormal_bone_marrow | 1.80674373 |
| 34 | MP0005671_abnormal_response_to | 1.80182315 |
| 35 | MP0002254_reproductive_system_inflammat | 1.79916827 |
| 36 | MP0000858_altered_metastatic_potential | 1.77033844 |
| 37 | MP0000716_abnormal_immune_system | 1.73419945 |
| 38 | MP0003724_increased_susceptibility_to | 1.69387256 |
| 39 | MP0008057_abnormal_DNA_replication | 1.69244343 |
| 40 | MP0000689_abnormal_spleen_morphology | 1.64442609 |
| 41 | MP0001853_heart_inflammation | 1.64271502 |
| 42 | MP0002429_abnormal_blood_cell | 1.62599449 |
| 43 | MP0002405_respiratory_system_inflammati | 1.60167454 |
| 44 | MP0005464_abnormal_platelet_physiology | 1.59466985 |
| 45 | MP0003077_abnormal_cell_cycle | 1.58073781 |
| 46 | MP0003111_abnormal_nucleus_morphology | 1.56139572 |
| 47 | MP0002722_abnormal_immune_system | 1.55272499 |
| 48 | MP0001533_abnormal_skeleton_physiology | 1.53014544 |
| 49 | MP0001845_abnormal_inflammatory_respons | 1.51331210 |
| 50 | MP0008260_abnormal_autophagy | 1.48757327 |
| 51 | MP0010094_abnormal_chromosome_stability | 1.47378796 |
| 52 | MP0004808_abnormal_hematopoietic_stem | 1.46896417 |
| 53 | MP0003866_abnormal_defecation | 1.44758222 |
| 54 | MP0000015_abnormal_ear_pigmentation | 1.43347432 |
| 55 | MP0006082_CNS_inflammation | 1.42266878 |
| 56 | MP0004019_abnormal_vitamin_homeostasis | 1.40549763 |
| 57 | MP0008058_abnormal_DNA_repair | 1.39834610 |
| 58 | MP0005075_abnormal_melanosome_morpholog | 1.37336099 |
| 59 | MP0005310_abnormal_salivary_gland | 1.36756618 |
| 60 | MP0002166_altered_tumor_susceptibility | 1.36012669 |
| 61 | MP0008438_abnormal_cutaneous_collagen | 1.35288324 |
| 62 | MP0001545_abnormal_hematopoietic_system | 1.34690731 |
| 63 | MP0005397_hematopoietic_system_phenotyp | 1.34690731 |
| 64 | MP0010234_abnormal_vibrissa_follicle | 1.34075000 |
| 65 | MP0003123_paternal_imprinting | 1.33453742 |
| 66 | MP0000465_gastrointestinal_hemorrhage | 1.30795139 |
| 67 | MP0008932_abnormal_embryonic_tissue | 1.29833707 |
| 68 | MP0008469_abnormal_protein_level | 1.28116614 |
| 69 | MP0005360_urolithiasis | 1.26049774 |
| 70 | MP0003075_altered_response_to | 1.24386285 |
| 71 | MP0000358_abnormal_cell_content/ | 1.23143812 |
| 72 | MP0010307_abnormal_tumor_latency | 1.22307138 |
| 73 | MP0008007_abnormal_cellular_replicative | 1.21933566 |
| 74 | MP0005379_endocrine/exocrine_gland_phen | 1.21518174 |
| 75 | MP0001764_abnormal_homeostasis | 1.19883167 |
| 76 | MP0005408_hypopigmentation | 1.19230544 |
| 77 | MP0010155_abnormal_intestine_physiology | 1.17127378 |
| 78 | MP0003763_abnormal_thymus_physiology | 1.16575264 |
| 79 | MP0002095_abnormal_skin_pigmentation | 1.16015092 |
| 80 | MP0003453_abnormal_keratinocyte_physiol | 1.15847376 |
| 81 | MP0002019_abnormal_tumor_incidence | 1.15119130 |
| 82 | MP0000678_abnormal_parathyroid_gland | 1.13503475 |
| 83 | MP0000609_abnormal_liver_physiology | 1.11251112 |
| 84 | MP0000703_abnormal_thymus_morphology | 1.10762341 |
| 85 | MP0003448_altered_tumor_morphology | 1.10084446 |
| 86 | MP0005319_abnormal_enzyme/_coenzyme | 1.09432650 |
| 87 | MP0003329_amyloid_beta_deposits | 1.08518089 |
| 88 | MP0002796_impaired_skin_barrier | 1.06466056 |
| 89 | MP0002006_tumorigenesis | 1.06215980 |
| 90 | MP0002877_abnormal_melanocyte_morpholog | 1.04014288 |
| 91 | MP0005257_abnormal_intraocular_pressure | 0.98842245 |
| 92 | MP0000313_abnormal_cell_death | 0.98754665 |
| 93 | MP0006035_abnormal_mitochondrial_morpho | 0.96431286 |
| 94 | MP0009643_abnormal_urine_homeostasis | 0.95794373 |
| 95 | MP0005501_abnormal_skin_physiology | 0.95788886 |
| 96 | MP0000343_altered_response_to | 0.94821197 |
| 97 | MP0003191_abnormal_cellular_cholesterol | 0.92037168 |
| 98 | MP0005083_abnormal_biliary_tract | 0.90434422 |
| 99 | MP0004264_abnormal_extraembryonic_tissu | 0.89189825 |
| 100 | MP0003656_abnormal_erythrocyte_physiolo | 0.88778947 |
| 101 | MP0002933_joint_inflammation | 0.88028509 |
| 102 | MP0009672_abnormal_birth_weight | 0.87025310 |
| 103 | MP0000598_abnormal_liver_morphology | 0.86956710 |
| 104 | MP0002277_abnormal_respiratory_mucosa | 0.85474859 |
| 105 | MP0003186_abnormal_redox_activity | 0.84966788 |
| 106 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.83268460 |
| 107 | MP0001730_embryonic_growth_arrest | 0.82747345 |
| 108 | MP0005164_abnormal_response_to | 0.82703487 |
| 109 | MP0005332_abnormal_amino_acid | 0.82484160 |
| 110 | MP0005084_abnormal_gallbladder_morpholo | 0.81717734 |
| 111 | MP0002163_abnormal_gland_morphology | 0.80211152 |
| 112 | MP0001727_abnormal_embryo_implantation | 0.79085400 |
| 113 | MP0008875_abnormal_xenobiotic_pharmacok | 0.78998125 |
| 114 | MP0001666_abnormal_nutrient_absorption | 0.78753241 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.77565379 |
| 116 | MP0000681_abnormal_thyroid_gland | 0.77338586 |
| 117 | MP0009278_abnormal_bone_marrow | 0.76600182 |
| 118 | MP0005390_skeleton_phenotype | 0.75562010 |
| 119 | MP0001663_abnormal_digestive_system | 0.75219723 |
| 120 | MP0003795_abnormal_bone_structure | 0.74938264 |
| 121 | MP0003300_gastrointestinal_ulcer | 0.74551449 |
| 122 | MP0004947_skin_inflammation | 0.74214431 |
| 123 | MP0000350_abnormal_cell_proliferation | 0.74210345 |
| 124 | MP0001873_stomach_inflammation | 0.70118464 |
| 125 | MP0003566_abnormal_cell_adhesion | 0.69230191 |
| 126 | MP0002693_abnormal_pancreas_physiology | 0.69168117 |
| 127 | MP0002998_abnormal_bone_remodeling | 0.67109439 |
| 128 | MP0002132_abnormal_respiratory_system | 0.66358288 |
| 129 | MP0008873_increased_physiological_sensi | 0.63948175 |
| 130 | MP0005384_cellular_phenotype | 0.62518015 |
| 131 | MP0005220_abnormal_exocrine_pancreas | 0.62031278 |
| 132 | MP0000604_amyloidosis | 0.60889770 |
| 133 | MP0001542_abnormal_bone_strength | 0.60880288 |
| 134 | MP0003786_premature_aging | 0.58435924 |
| 135 | MP0002135_abnormal_kidney_morphology | 0.57609103 |
| 136 | MP0003122_maternal_imprinting | 0.57201551 |
| 137 | MP0006036_abnormal_mitochondrial_physio | 0.56607898 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of cells of the erythroid lineage (HP:0012130) | 5.96713862 |
| 2 | Abnormal number of erythroid precursors (HP:0012131) | 5.58317671 |
| 3 | Recurrent abscess formation (HP:0002722) | 4.86594595 |
| 4 | Reticulocytopenia (HP:0001896) | 4.76560449 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 4.72276105 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 4.34471474 |
| 7 | Thrombocytosis (HP:0001894) | 4.04330991 |
| 8 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.84162965 |
| 9 | Pallor (HP:0000980) | 3.83488515 |
| 10 | Macrocytic anemia (HP:0001972) | 3.78218920 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.53387728 |
| 12 | Loss of speech (HP:0002371) | 3.33381424 |
| 13 | Type I transferrin isoform profile (HP:0003642) | 3.31434278 |
| 14 | Chronic obstructive pulmonary disease (HP:0006510) | 3.20274816 |
| 15 | Obstructive lung disease (HP:0006536) | 3.20274816 |
| 16 | Poor head control (HP:0002421) | 3.18486588 |
| 17 | Dysostosis multiplex (HP:0000943) | 3.17889415 |
| 18 | Petechiae (HP:0000967) | 3.15819664 |
| 19 | Abnormality of macrophages (HP:0004311) | 3.15269875 |
| 20 | IgM deficiency (HP:0002850) | 3.14891441 |
| 21 | Agnosia (HP:0010524) | 3.06969989 |
| 22 | Progressive neurologic deterioration (HP:0002344) | 3.04627149 |
| 23 | Exertional dyspnea (HP:0002875) | 3.00398535 |
| 24 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.95575013 |
| 25 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89673070 |
| 26 | Increased cerebral lipofuscin (HP:0011813) | 2.87198612 |
| 27 | Mitochondrial inheritance (HP:0001427) | 2.85896552 |
| 28 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.85357971 |
| 29 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.85110519 |
| 30 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.83335463 |
| 31 | Mucopolysacchariduria (HP:0008155) | 2.83335463 |
| 32 | Reduced antithrombin III activity (HP:0001976) | 2.80536209 |
| 33 | Hepatocellular necrosis (HP:0001404) | 2.79690318 |
| 34 | Increased hepatocellular lipid droplets (HP:0006565) | 2.78531273 |
| 35 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.76364865 |
| 36 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.76364865 |
| 37 | Abnormal protein glycosylation (HP:0012346) | 2.76364865 |
| 38 | Abnormal glycosylation (HP:0012345) | 2.76364865 |
| 39 | Myositis (HP:0100614) | 2.73684564 |
| 40 | Acute necrotizing encephalopathy (HP:0006965) | 2.73345108 |
| 41 | Abnormality of glycolipid metabolism (HP:0010969) | 2.68297451 |
| 42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.68297451 |
| 43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.68297451 |
| 44 | Recurrent skin infections (HP:0001581) | 2.61383196 |
| 45 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.60890380 |
| 46 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50165229 |
| 47 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50165229 |
| 48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50165229 |
| 49 | Purpura (HP:0000979) | 2.45764247 |
| 50 | Cellulitis (HP:0100658) | 2.44733898 |
| 51 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.44410651 |
| 52 | Deep venous thrombosis (HP:0002625) | 2.40996945 |
| 53 | Hepatic necrosis (HP:0002605) | 2.38953816 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.38779245 |
| 55 | Lipid accumulation in hepatocytes (HP:0006561) | 2.38287774 |
| 56 | Meningitis (HP:0001287) | 2.37391220 |
| 57 | Prolonged neonatal jaundice (HP:0006579) | 2.35799977 |
| 58 | Increased CSF lactate (HP:0002490) | 2.31808445 |
| 59 | Aplastic anemia (HP:0001915) | 2.30434707 |
| 60 | Recurrent viral infections (HP:0004429) | 2.28127163 |
| 61 | Renal Fanconi syndrome (HP:0001994) | 2.27294292 |
| 62 | Mediastinal lymphadenopathy (HP:0100721) | 2.26908699 |
| 63 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.26412451 |
| 64 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.26412451 |
| 65 | Hypoglycemic seizures (HP:0002173) | 2.26275808 |
| 66 | Increased serum ferritin (HP:0003281) | 2.25713450 |
| 67 | Thoracic kyphosis (HP:0002942) | 2.23793731 |
| 68 | Microretrognathia (HP:0000308) | 2.23549543 |
| 69 | J-shaped sella turcica (HP:0002680) | 2.23390724 |
| 70 | Xanthomatosis (HP:0000991) | 2.21733611 |
| 71 | Hepatosplenomegaly (HP:0001433) | 2.19568001 |
| 72 | Abnormality of T cell physiology (HP:0011840) | 2.19171208 |
| 73 | Cardiomegaly (HP:0001640) | 2.17134790 |
| 74 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.15356086 |
| 75 | Chronic otitis media (HP:0000389) | 2.14721120 |
| 76 | Hypokinesia (HP:0002375) | 2.14691980 |
| 77 | Systemic lupus erythematosus (HP:0002725) | 2.13535312 |
| 78 | Amyloidosis (HP:0011034) | 2.13501479 |
| 79 | Gastrointestinal inflammation (HP:0004386) | 2.12993476 |
| 80 | Basal ganglia calcification (HP:0002135) | 2.11028957 |
| 81 | Hypertensive crisis (HP:0100735) | 2.07587555 |
| 82 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.07572437 |
| 83 | Inflammation of the large intestine (HP:0002037) | 2.07524628 |
| 84 | Hypoglycemic coma (HP:0001325) | 2.06390085 |
| 85 | Progressive macrocephaly (HP:0004481) | 2.06086888 |
| 86 | Microvesicular hepatic steatosis (HP:0001414) | 2.05592983 |
| 87 | Abnormality of reticulocytes (HP:0004312) | 2.04936892 |
| 88 | Progressive muscle weakness (HP:0003323) | 2.04410150 |
| 89 | Nuclear cataract (HP:0100018) | 2.03734616 |
| 90 | Colitis (HP:0002583) | 2.02800107 |
| 91 | Recurrent fungal infections (HP:0002841) | 2.01769931 |
| 92 | Polygenic inheritance (HP:0010982) | 2.01458494 |
| 93 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.00122989 |
| 94 | Interstitial pulmonary disease (HP:0006530) | 1.97239058 |
| 95 | Recurrent lower respiratory tract infections (HP:0002783) | 1.96751154 |
| 96 | Recurrent pneumonia (HP:0006532) | 1.96499999 |
| 97 | Acute encephalopathy (HP:0006846) | 1.95640632 |
| 98 | Abnormality of the thoracic spine (HP:0100711) | 1.93756889 |
| 99 | Vertebral compression fractures (HP:0002953) | 1.93058809 |
| 100 | Disinhibition (HP:0000734) | 1.92830303 |
| 101 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.91378469 |
| 102 | Prolonged partial thromboplastin time (HP:0003645) | 1.91344937 |
| 103 | Abnormality of the anterior horn cell (HP:0006802) | 1.91053707 |
| 104 | Degeneration of anterior horn cells (HP:0002398) | 1.91053707 |
| 105 | Pathologic fracture (HP:0002756) | 1.90913994 |
| 106 | Orthostatic hypotension (HP:0001278) | 1.90596465 |
| 107 | Glomerulonephritis (HP:0000099) | 1.89408381 |
| 108 | Gingivitis (HP:0000230) | 1.89022321 |
| 109 | Seborrheic dermatitis (HP:0001051) | 1.88991419 |
| 110 | Symptomatic seizures (HP:0011145) | 1.88627545 |
| 111 | Cholecystitis (HP:0001082) | 1.88293918 |
| 112 | Abnormal gallbladder physiology (HP:0012438) | 1.88293918 |
| 113 | Increased intramyocellular lipid droplets (HP:0012240) | 1.86417348 |
| 114 | Nonimmune hydrops fetalis (HP:0001790) | 1.86363298 |
| 115 | Multiple enchondromatosis (HP:0005701) | 1.85829257 |
| 116 | Abnormality of complement system (HP:0005339) | 1.85465672 |
| 117 | Beaking of vertebral bodies (HP:0004568) | 1.85239719 |
| 118 | Personality changes (HP:0000751) | 1.84493608 |
| 119 | Increased IgE level (HP:0003212) | 1.83654722 |
| 120 | Abnormal platelet function (HP:0011869) | 1.83439837 |
| 121 | Impaired platelet aggregation (HP:0003540) | 1.83439837 |
| 122 | Axonal loss (HP:0003447) | 1.82430446 |
| 123 | Oral leukoplakia (HP:0002745) | 1.81011326 |
| 124 | Vasculitis (HP:0002633) | 1.80762289 |
| 125 | Testicular atrophy (HP:0000029) | 1.80171388 |
| 126 | Respiratory failure (HP:0002878) | 1.79815925 |
| 127 | Cutaneous photosensitivity (HP:0000992) | 1.78394298 |
| 128 | Hypergammaglobulinemia (HP:0010702) | 1.77400784 |
| 129 | Complement deficiency (HP:0004431) | 1.77249975 |
| 130 | Urticaria (HP:0001025) | 1.75871952 |
| 131 | Pulmonary fibrosis (HP:0002206) | 1.75826466 |
| 132 | Osteomyelitis (HP:0002754) | 1.75640968 |
| 133 | Villous atrophy (HP:0011473) | 1.74910905 |
| 134 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.74910905 |
| 135 | Severe visual impairment (HP:0001141) | 1.74904640 |
| 136 | Abnormality of the prostate (HP:0008775) | 1.74041427 |
| 137 | Hypergonadotropic hypogonadism (HP:0000815) | 1.73433624 |
| 138 | Birth length less than 3rd percentile (HP:0003561) | 1.73084359 |
| 139 | Abnormality of the Achilles tendon (HP:0005109) | 1.70006986 |
| 140 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.68940859 |
| 141 | Respiratory difficulties (HP:0002880) | 1.67936432 |
| 142 | Progressive external ophthalmoplegia (HP:0000590) | 1.65570116 |
| 143 | Lower limb hyperreflexia (HP:0002395) | 1.65410952 |
| 144 | Abnormality of iron homeostasis (HP:0011031) | 1.64797125 |
| 145 | Gastrointestinal stroma tumor (HP:0100723) | 1.63448561 |
| 146 | Achilles tendon contracture (HP:0001771) | 1.61759312 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NME2 | 4.27575526 |
| 2 | BLK | 3.38716616 |
| 3 | VRK2 | 3.33090138 |
| 4 | STK16 | 3.04256194 |
| 5 | PIM2 | 2.90738005 |
| 6 | EIF2AK3 | 2.90603031 |
| 7 | TLK1 | 2.88286762 |
| 8 | SMG1 | 2.84526964 |
| 9 | IRAK4 | 2.51453334 |
| 10 | SCYL2 | 2.44972607 |
| 11 | ERN1 | 2.37079903 |
| 12 | KIT | 2.22460315 |
| 13 | MAP4K1 | 2.17123674 |
| 14 | BUB1 | 2.09941199 |
| 15 | PRPF4B | 2.01623319 |
| 16 | CDK12 | 1.98805950 |
| 17 | WEE1 | 1.91425624 |
| 18 | FLT3 | 1.82171629 |
| 19 | TBK1 | 1.79349400 |
| 20 | VRK1 | 1.78861306 |
| 21 | TYK2 | 1.78799870 |
| 22 | ARAF | 1.72913805 |
| 23 | IRAK3 | 1.72577786 |
| 24 | CSF1R | 1.71421290 |
| 25 | BTK | 1.70436700 |
| 26 | FES | 1.66961717 |
| 27 | TEC | 1.59968583 |
| 28 | TESK2 | 1.50932765 |
| 29 | SYK | 1.47259830 |
| 30 | ZAP70 | 1.42887797 |
| 31 | LRRK2 | 1.40680890 |
| 32 | EIF2AK1 | 1.38488627 |
| 33 | PDK2 | 1.33649429 |
| 34 | MAP3K11 | 1.28292028 |
| 35 | FGFR4 | 1.27300067 |
| 36 | TAOK2 | 1.25259099 |
| 37 | MAP3K14 | 1.23874982 |
| 38 | DYRK3 | 1.22988488 |
| 39 | ICK | 1.18642786 |
| 40 | MATK | 1.18391665 |
| 41 | SIK1 | 1.17778571 |
| 42 | RPS6KA4 | 1.17290151 |
| 43 | PASK | 1.16388850 |
| 44 | LYN | 1.13950122 |
| 45 | RIPK4 | 1.12752416 |
| 46 | CDK19 | 1.11053010 |
| 47 | MAP3K10 | 1.09580028 |
| 48 | GRK6 | 1.08651845 |
| 49 | TESK1 | 1.07034514 |
| 50 | CDC7 | 1.04602501 |
| 51 | TGFBR2 | 1.01617304 |
| 52 | ACVR1B | 1.01610199 |
| 53 | EPHA2 | 1.00808120 |
| 54 | BRAF | 1.00433039 |
| 55 | IRAK2 | 0.99734572 |
| 56 | TAOK1 | 0.99651735 |
| 57 | PKN2 | 0.99031972 |
| 58 | IKBKB | 0.95373834 |
| 59 | PAK4 | 0.93820826 |
| 60 | KDR | 0.93270820 |
| 61 | MST4 | 0.92088318 |
| 62 | CLK1 | 0.90812630 |
| 63 | MAPKAPK3 | 0.90622597 |
| 64 | MAP3K1 | 0.90361129 |
| 65 | EIF2AK2 | 0.89627215 |
| 66 | NEK2 | 0.89622733 |
| 67 | MAP2K3 | 0.83944430 |
| 68 | TGFBR1 | 0.83926309 |
| 69 | CAMKK2 | 0.83868329 |
| 70 | TNK2 | 0.83856414 |
| 71 | TAOK3 | 0.83106800 |
| 72 | MAP3K8 | 0.81070923 |
| 73 | CDK7 | 0.75757920 |
| 74 | LCK | 0.75658647 |
| 75 | ADRBK2 | 0.74001178 |
| 76 | BMX | 0.71676045 |
| 77 | RPS6KB2 | 0.71366167 |
| 78 | BCKDK | 0.70754937 |
| 79 | CDK8 | 0.70724284 |
| 80 | PTK6 | 0.69285374 |
| 81 | TTK | 0.68494544 |
| 82 | ILK | 0.68418390 |
| 83 | IKBKE | 0.68317358 |
| 84 | SRPK1 | 0.68153395 |
| 85 | PIM1 | 0.66936840 |
| 86 | NME1 | 0.66251947 |
| 87 | HCK | 0.65822247 |
| 88 | STK10 | 0.64987264 |
| 89 | JAK3 | 0.64955229 |
| 90 | ABL2 | 0.64453166 |
| 91 | EEF2K | 0.63903209 |
| 92 | AURKB | 0.63886705 |
| 93 | CDK6 | 0.63770613 |
| 94 | PDPK1 | 0.63522734 |
| 95 | PAK1 | 0.62834537 |
| 96 | PRKD2 | 0.61891734 |
| 97 | AURKA | 0.61704694 |
| 98 | MAPK11 | 0.61363778 |
| 99 | MAP3K13 | 0.60661280 |
| 100 | MAP2K2 | 0.60366349 |
| 101 | DAPK1 | 0.60302049 |
| 102 | NEK9 | 0.60050777 |
| 103 | MAP3K12 | 0.60035965 |
| 104 | DAPK3 | 0.60004377 |
| 105 | YES1 | 0.57608107 |
| 106 | FGR | 0.57524880 |
| 107 | PRKG2 | 0.55728279 |
| 108 | CSK | 0.54574313 |
| 109 | STK4 | 0.54043494 |
| 110 | ITK | 0.53356914 |
| 111 | CSNK2A1 | 0.53223836 |
| 112 | ATR | 0.52665551 |
| 113 | RPS6KA6 | 0.51735599 |
| 114 | CSNK2A2 | 0.51495790 |
| 115 | TRIB3 | 0.49825398 |
| 116 | RPS6KA5 | 0.49755537 |
| 117 | GRK7 | 0.48795734 |
| 118 | RPS6KL1 | 0.48771025 |
| 119 | RPS6KC1 | 0.48771025 |
| 120 | PLK1 | 0.48684076 |
| 121 | LMTK2 | 0.46420709 |
| 122 | PLK4 | 0.45888007 |
| 123 | MKNK1 | 0.45477508 |
| 124 | PRKCD | 0.44927775 |
| 125 | HIPK2 | 0.43024980 |
| 126 | MAPKAPK2 | 0.41773436 |
| 127 | CDK4 | 0.41546548 |
| 128 | ALK | 0.40960861 |
| 129 | EPHB1 | 0.40187300 |
| 130 | MAP3K3 | 0.39457036 |
| 131 | MAPKAPK5 | 0.38104849 |
| 132 | BMPR2 | 0.38101131 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 5.40861123 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 3.98745210 |
| 3 | Protein export_Homo sapiens_hsa03060 | 3.29444158 |
| 4 | Proteasome_Homo sapiens_hsa03050 | 3.07197369 |
| 5 | Mismatch repair_Homo sapiens_hsa03430 | 2.85455915 |
| 6 | Other glycan degradation_Homo sapiens_hsa00511 | 2.64988578 |
| 7 | Base excision repair_Homo sapiens_hsa03410 | 2.20530385 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.17361694 |
| 9 | Homologous recombination_Homo sapiens_hsa03440 | 2.10463934 |
| 10 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.07230256 |
| 11 | RNA polymerase_Homo sapiens_hsa03020 | 1.98992388 |
| 12 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.91242937 |
| 13 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.88710127 |
| 14 | Spliceosome_Homo sapiens_hsa03040 | 1.87618338 |
| 15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.83749983 |
| 16 | Parkinsons disease_Homo sapiens_hsa05012 | 1.79965119 |
| 17 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.79441212 |
| 18 | Lysosome_Homo sapiens_hsa04142 | 1.76940617 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.69042026 |
| 20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.61446407 |
| 21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.57009327 |
| 22 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.44001787 |
| 23 | Leishmaniasis_Homo sapiens_hsa05140 | 1.32774901 |
| 24 | Huntingtons disease_Homo sapiens_hsa05016 | 1.29321486 |
| 25 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.27506187 |
| 26 | Alzheimers disease_Homo sapiens_hsa05010 | 1.26281103 |
| 27 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.23392105 |
| 28 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.23325475 |
| 29 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.23042132 |
| 30 | Sulfur relay system_Homo sapiens_hsa04122 | 1.21878129 |
| 31 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20107559 |
| 32 | Phagosome_Homo sapiens_hsa04145 | 1.19952717 |
| 33 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.19453606 |
| 34 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.15842477 |
| 35 | Allograft rejection_Homo sapiens_hsa05330 | 1.15487781 |
| 36 | RNA transport_Homo sapiens_hsa03013 | 1.13913315 |
| 37 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.13383632 |
| 38 | Legionellosis_Homo sapiens_hsa05134 | 1.11384330 |
| 39 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.10825005 |
| 40 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.09945811 |
| 41 | One carbon pool by folate_Homo sapiens_hsa00670 | 1.07240688 |
| 42 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.05614929 |
| 43 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.05347436 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 1.04114816 |
| 45 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.03891222 |
| 46 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.03870482 |
| 47 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 1.01261705 |
| 48 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.00203406 |
| 49 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.96463169 |
| 50 | Cell cycle_Homo sapiens_hsa04110 | 0.95290159 |
| 51 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.95091495 |
| 52 | Tuberculosis_Homo sapiens_hsa05152 | 0.94278921 |
| 53 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.93743576 |
| 54 | Prion diseases_Homo sapiens_hsa05020 | 0.93352357 |
| 55 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.92176688 |
| 56 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.91503501 |
| 57 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.90837392 |
| 58 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.90773854 |
| 59 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.90479811 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90114212 |
| 61 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.89074257 |
| 62 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.87265036 |
| 63 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.86221044 |
| 64 | Apoptosis_Homo sapiens_hsa04210 | 0.85636299 |
| 65 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.84766675 |
| 66 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.84336220 |
| 67 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.83932849 |
| 68 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.81053736 |
| 69 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.80859505 |
| 70 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80559862 |
| 71 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.80271328 |
| 72 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.80224873 |
| 73 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.79958780 |
| 74 | Shigellosis_Homo sapiens_hsa05131 | 0.78982608 |
| 75 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.78779997 |
| 76 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77337819 |
| 77 | Measles_Homo sapiens_hsa05162 | 0.76454148 |
| 78 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.73671880 |
| 79 | Asthma_Homo sapiens_hsa05310 | 0.73595428 |
| 80 | Purine metabolism_Homo sapiens_hsa00230 | 0.69903774 |
| 81 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.67874651 |
| 82 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.66253410 |
| 83 | Basal transcription factors_Homo sapiens_hsa03022 | 0.65605334 |
| 84 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.65003710 |
| 85 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64968842 |
| 86 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.64725638 |
| 87 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.64073594 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.64052766 |
| 89 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.63974529 |
| 90 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.63031202 |
| 91 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.62279780 |
| 92 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.62213616 |
| 93 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.59477011 |
| 94 | RNA degradation_Homo sapiens_hsa03018 | 0.58113044 |
| 95 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.56789689 |
| 96 | Hepatitis B_Homo sapiens_hsa05161 | 0.56706490 |
| 97 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.55491720 |
| 98 | Bladder cancer_Homo sapiens_hsa05219 | 0.55088952 |
| 99 | Influenza A_Homo sapiens_hsa05164 | 0.55032084 |
| 100 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.54557465 |
| 101 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.54431707 |
| 102 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.53543411 |
| 103 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.53510385 |
| 104 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.53179467 |
| 105 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.52062679 |
| 106 | Malaria_Homo sapiens_hsa05144 | 0.50596355 |
| 107 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.50514784 |
| 108 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.50354953 |
| 109 | Hepatitis C_Homo sapiens_hsa05160 | 0.50129244 |
| 110 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.49896206 |
| 111 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.46733665 |
| 112 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.45871050 |
| 113 | Salmonella infection_Homo sapiens_hsa05132 | 0.45643194 |
| 114 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.44941364 |
| 115 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.44924019 |
| 116 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.43716931 |
| 117 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.43474216 |
| 118 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.43394384 |
| 119 | Viral myocarditis_Homo sapiens_hsa05416 | 0.43034155 |
| 120 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.40900585 |
| 121 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.40574584 |
| 122 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.40379519 |
| 123 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.39799318 |
| 124 | Alcoholism_Homo sapiens_hsa05034 | 0.39476982 |
| 125 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.38610416 |
| 126 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.37796885 |
| 127 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.35982796 |
| 128 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.35085653 |
| 129 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.33401272 |
| 130 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33030644 |
| 131 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.30956927 |
| 132 | HTLV-I infection_Homo sapiens_hsa05166 | 0.30437592 |
| 133 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.29983846 |
| 134 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29573861 |
| 135 | Metabolic pathways_Homo sapiens_hsa01100 | 0.28137110 |

